We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Laboratory Medicine and Nosocomial Infections: How Norway Reduces MRSA

By LabMedica International staff writers
Posted on 18 Feb 2010
Norwegian hospitals have had considerable success in their anti-methicillin-resistant Staphylococcus aureus (MRSA) efforts. More...


The country introduced strict control on antibiotic use that resulted in far fewer cases of the MRSA infections. An estimated 19,000 patients in U.S. hospitals died each year following MRSA infection, and observers are suggesting that the U.S. healthcare system could reduce those cases by replicating the Scandinavian country's control program.

How does Norway do it? Norwegian doctors prescribe fewer antibiotics than any other country, so people do not have a chance to develop resistance to them. Patients with MRSA are isolated and medical staff members who test positive stay at home. Doctors track each case of MRSA by its individual strain, interviewing patients about where they have been and who they have been with testing anyone who has been in contact with them.

"It's a very sad situation that in some places so many are dying from this, because we have shown here in Norway that methicillin-resistant Staphylococcus aureus can be controlled, and with not too much effort," said Jan Hendrik-Binder, Oslo's MRSA medical adviser. "But you have to take it seriously, you have to give it attention, and you must not give up."

Now a spate of new studies from around the world proves that Norway's model can be replicated with extraordinary success, and public health experts are saying deaths from MRSA are unnecessary.

In a small public hospital called the Queen Elizabeth Hospital Kings Lynn, NHS Trust (UK), about 100 miles outside of London (UK) microbiologist Prof. Lynne Liebowitz noticed the low Nordic MRSA rates, while the numbers in her hospital were increasing.

Prof. Liebowitz asked doctors to stop almost completely using two groups of antibiotics (fluoroquinolones and/or cephalosporins) known for provoking MRSA infections. One month later, MRSA rates were tumbling. In 2003, when the study started the hospital had 47 MRSA bloodstream infections. In 2008, they had one. This has been replicated at four other hospitals, all with the same results.

Related Links:
Queen Elizabeth Hospital Kings Lynn




New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Serological Pipet Controller
PIPETBOY GENIUS
New
Urine Chemistry Control
Dropper Urine Chemistry Control
New
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image

Bioluminescent Molecular Diagnostics Platform Enables Rapid On-Site Pathogen Detection

Infectious diseases such as malaria, gonorrhea, and chlamydia continue to pose serious global health challenges, particularly in low-income countries with limited healthcare infrastructure.... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.